Moderna
Trade Moderna 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About MRNA
Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics.
MRNA Key Statistics
MRNA News
Moderna (MRNA) is in the spotlight following its announcement of strong new clinical data for the updated Spikevax COVID-19 vaccine, specifically targeting the...
On Tuesday, U.S. markets slipped, with the Dow Jones Industrial Average falling about 0.3% to 45,757.90, the S&P 500 retreating 0.1% to 6,606.76, and the Nasdaq...
Moderna is up on the release of positive results for reformulated Covid vaccine Moderna rose on Tuesday after it announced encouraging trial results for its ne...
Analyst ratings
59%
of 27 ratingsMore MRNA News
Moderna Inc. MRNA on Tuesday released preliminary immunogenicity data for the 2025-2026 formula of Spikevax, which targets the LP.8.1 variant of SARS-CoV-2 to h...
Moderna (MRNA) announced “positive” preliminary immunogenicity data for the 2025-2026 formula of Spikevax, which targets the LP.8.1 variant of SARS-CoV-2 to hel...
In early September 2025, Moderna faced heightened scrutiny after reports surfaced that U.S. health officials plan to present claims linking COVID-19 vaccines to...